Y200-6827 Screening compound: 1-(2,3-dihydro-1,4-benzodioxine-6-carbonyl)-4-(2-phenylethyl)piperazine

Y200-6827 Screening compound: 1-(2,3-dihydro-1,4-benzodioxine-6-carbonyl)-4-(2-phenylethyl)piperazine
Y200-6827 Screening compound: 1-(2,3-dihydro-1,4-benzodioxine-6-carbonyl)-4-(2-phenylethyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-6827
1-(2,3-dihydro-1,4-benzodioxine-6-carbonyl)-4-(2-phenylethyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-6827

Molecular Formula

C21H24N2O3 (C21 H24 N2 O3)

Compound Name

1-(2,3-dihydro-1,4-benzodioxine-6-carbonyl)-4-(2-phenylethyl)piperazine

IUPAC name

1-(23-dihydro-14-benzodioxine-6-carbonyl)-4-(2-phenylethyl)piperazine

SMILES

O=C(c(cc1)cc2c1OCCO2)N1CCN(CCc2ccccc2)CC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

352.43

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.652

Distribution Coefficient, logD

1.622

Water Solubility, LogSw

-1.90

Polar Surface Area

36.229

Acid Dissociation Constant (pKa)

26.47

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.10

Y200-6827 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS BBB Library (22607 compounds)

CNS Targets (44014 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Cardiovascular
Mechanism of action:
  • Epigenetic
Targets:
  • Proteases
  • Ion Channels

References: we are preparing a list of scientific research reports with Y200-6827 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-6827?
Check Price and Availability of Y200-6827, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-6827 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-6827
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-6827
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-6827 available by request